Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-07-045839
Filing Date
2007-08-22
Accepted
2007-08-22 16:41:53
Documents
1
Period of Report
2007-08-21

Document Format Files

Seq Description Document Type Size
1 v085974_ex.html 3  
1 v085974_ex.xml 3 2363
  Complete submission text file 0001144204-07-045839.txt   4174
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD. 711 EXECUTIVE BLVD., SUITE Q VALLEY COTTAGE NY 10989
Business Address 845-267-0707
Kessler William (Reporting) CIK: 0001410538 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 071073398